+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

  • ID: 5118232
  • Report
  • June 2020
  • Region: Global
  • 112 pages
  • IMARC Group
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Atricure Inc.
  • Biotronik
  • Cardiofocus Inc.
  • Johnson & Johnson
  • Stereotaxis Inc.
  • MORE
The global atrial fibrillation treatment market grew at a CAGR of around 14% during 2014-2019. Atrial fibrillation (AFib) refers to a cardiac condition with irregular and rapid heart rate that increases the risks of stroke, heart failure and other heart-related complications. In this condition, the upper (atrial) chambers beat irregularly and out of coordination with the lower (ventricle) chambers of the heart, thereby causing heart palpitations, shortness of breath and fatigue. It can also lead to the development of blood clots that may disrupt the blood flow to other organs. The main types of AFib include paroxysmal, persistent, long-term persistent, and permanent AFib that can be treated with medications and other interventions to adjust the heart’s electrical impulses.

The rising prevalence of cardiovascular diseases (CVDs) is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs). This, along with the steadily increasing geriatric population across the globe, is providing a boost to the market growth. Furthermore, the increasing preference for minimally invasive (MI) surgical procedures is also creating a positive impact on the demand for miniaturized surgical devices, implant surgeries and remote nursing. Additionally, various technological advancements, such as the development of catheter ablation devices to remove damaged heart tissues and innovative mapping and recording systems, is acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further. Looking forward, the publisher expects the market to continue its strong growth during the next five years.

Breakup by Disorder Type:
  • Paroxysmal Atrial Fibrillation
  • Persistent Atrial Fibrillation
  • Permanent Atrial Fibrillation
  • Others
Breakup by Treatment Type:
  • Medical Procedures
  • Surgical Procedures
  • Maze Surgery
  • Catheter Ablation
Non-Surgical Procedures
  • Electric Cardioversion
  • Diagnostic Catheters
  • Mapping and Recording Systems
  • Cardiac Monitors
  • Access Devices
  • Left Atrial Appendage and Closure Devices
  • Intracardiac Echocardiography (ICE) Systems
  • Medication
  • Anticoagulants
  • Anti-Arrhythmics
Breakup by End-User:
  • Hospitals
  • Cardiac Labs
  • Ambulatory Surgical Centers
  • Others
Breakup by Region:
  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Atricure Inc., Biotronik, Boston Scientific Corporation, Cardiofocus Inc., Hansen Medical Inc. (Auris Health), Johnson & Johnson, Siemens Healthineers (Cerner Corporation), Stereotaxis Inc., etc.

Key Questions Answered in this Report:
  • How has the global atrial fibrillation treatment market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the disorder type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global atrial fibrillation market treatment and who are the key players?
  • What is the degree of competition in the industry?
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Atricure Inc.
  • Biotronik
  • Cardiofocus Inc.
  • Johnson & Johnson
  • Stereotaxis Inc.
  • MORE
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Atrial Fibrillation Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Forecast

6 Market Breakup by Disorder Type
6.1 Paroxysmal Atrial Fibrillation
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Persistent Atrial Fibrillation
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Permanent Atrial Fibrillation
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast

7 Market Breakup by Treatment Type
7.1 Medical Procedures
7.1.1 Market Trends
7.1.2 Surgical Procedures
7.1.2.1 Maze Surgery
7.1.2.2 Catheter Ablation
7.1.3 Non-Surgical Devices
7.1.3.1 Electric Cardioversion
7.1.3.2 Diagnostic Catheters
7.1.3.3 Mapping and Recording Systems
7.1.3.4 Cardiac Monitors
7.1.3.5 Access Devices
7.1.3.6 Left Atrial Appendage and Closure Devices
7.1.3.7 Intracardiac Echocardiography (ICE) Systems
7.1.4 Market Forecast
7.2 Medications
7.2.1 Market Trends
7.2.2 Drug Classes
7.2.2.1 Anticoagulants
7.2.2.2 Anti-Arrhythmics
7.2.3 Market Forecast

8 Market Breakup by End-User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cardiac Labs
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Ambulatory Surgical Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast

9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Atricure Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Biosense Webster Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 Biotronik
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 SWOT Analysis
13.3.5 Cardiofocus Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 Hansen Medical Inc. (Auris Health)
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 Johnson & Johnson
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Siemens Healthineers (Cerner Corporation)
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.9 Stereotaxis Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
Note: Product cover images may vary from those shown
3 of 4
  • Abbott Laboratories
  • Atricure Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Cardiofocus Inc.
  • Hansen Medical Inc. (Auris Health)
  • Johnson & Johnson
  • Siemens Healthineers (Cerner Corporation)
  • Stereotaxis Inc.
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll